Inventor · disambiguated record
Patricius Hendrikus Cornelis Van Berkel
Also filed as: VAN BERKEL PATRICIUS H C · VAN BERKEL PATRICIUS HENDRIKUS · VAN BERKEL PATRICIUS HENDRIKUS CORNELIS
28 granted patents·36 pending applications·96 citations·filing 2011–2024
95Inventor score
Top patents by PatentIndex Score
64 records- 0193US10934571B2Recombinant production of mixtures of antibodiesMERUS NV·Filed 2016·Granted Mar 2, 2021·4 cites·20 claims
- 0293US10010624B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2014·Granted Jul 3, 2018·9 cites·11 claims
- 0393US9919056B2Pyrrolobenzodiazepine-anti-CD22 antibody conjugatesADC THERAPEUTICS S A·Filed 2013·Granted Mar 20, 2018·8 cites·12 claims
- 0492US10799596B2Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS S A·Filed 2018·Granted Oct 13, 2020·4 cites·12 claims
- 0591US9950078B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2014·Granted Apr 24, 2018·7 cites·11 claims
- 0691US9931414B2Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS S A·Filed 2013·Granted Apr 3, 2018·13 cites·16 claims
- 0790US10736903B2Pyrrolobenzodiazepine-anti-PSMA antibody conjugatesMEDIMMUNE LTD·Filed 2013·Granted Aug 11, 2020·5 cites·6 claims
- 0889US9931415B2Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS S A·Filed 2013·Granted Apr 3, 2018·10 cites·17 claims
- 0987US10751346B2Pyrrolobenzodiazepine—anti-PSMA antibody conjugatesMEDIMMUNE LTD·Filed 2013·Granted Aug 25, 2020·4 cites·10 claims
- 1087US10695433B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2013·Granted Jun 30, 2020·4 cites·8 claims
- 1187US10544223B2Combination therapy with an anti-axl antibody-drug conjugateADC THERAPEUTICS SA·Filed 2018·Granted Jan 28, 2020·5 cites·21 claims
- 1286US11779650B2Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS S A·Filed 2020·Granted Oct 10, 2023·1 cites·13 claims
- 1386US11771775B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2020·Granted Oct 3, 2023·1 cites·20 claims
- 1486US11160872B2Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS SA·Filed 2018·Granted Nov 2, 2021·2 cites·24 claims
- 1586US10780181B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2018·Granted Sep 22, 2020·2 cites·11 claims
- 1684US9303081B2Recombinant production of mixtures of antibodiesVAN BERKEL PATRICIUS H C·Filed 2011·Granted Apr 5, 2016·6 cites·14 claims
- 1783US9956299B2Pyrrolobenzodiazepine—antibody conjugatesMEDIMMUNE LTD·Filed 2014·Granted May 1, 2018·5 cites·12 claims
- 1882US11596696B2Combination therapy with an anti-CD25 antibody-drug conjugateADC THERAPEUTICS SA·Filed 2018·Granted Mar 7, 2023·3 cites·13 claims
- 1981US10722594B2Pyrrolobenzodiazepine-anti-CD22 antibody conjugatesHOWARD PHILIP WILSON·Filed 2018·Granted Jul 28, 2020·1 cites·11 claims
- 2079US11612665B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2018·Granted Mar 28, 2023·1 cites·21 claims
- 2173USRE47770ERecombinant production of mixtures of antibodiesMERUS NV·Filed 2016·Granted Dec 17, 2019·1 cites·26 claims
- 2272US11702473B2Site-specific antibody-drug conjugatesMEDIMMUNE LTD·Filed 2019·Granted Jul 18, 2023·0 cites·10 claims
- 2372US2018094289A1Recombinant production of mixtures of antibodiesMERUS NV·Filed 2017·Application pending·0 cites
- 2470US11690918B2Pyrrolobenzodiazepine-anti-CD22 antibody conjugatesADC THERAPEUTICS S A·Filed 2020·Granted Jul 4, 2023·0 cites·15 claims
- 2570US2024269314A1Pyrrolobenzodiazepine-antibody conjugates and uses thereofADC THERAPEUTICS SA·Filed 2024·Application pending·0 cites
- 2669US2023053603A1Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 2768US2018112247A1Recombinant production of mixtures of antibodiesMERUS NV·Filed 2017·Application pending·0 cites
- 2867US11813335B2Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS SA·Filed 2021·Granted Nov 14, 2023·0 cites·17 claims
- 2967US2013243773A1Recombinant production of mixtures of antibodiesMERUS B V·Filed 2013·Application pending·0 cites
- 3066US2021113587A1Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS SA·Filed 2020·Application pending·0 cites
- 3166US2023149556A1Combination therapyADC THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 3265US11484606B2Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS SA·Filed 2021·Granted Nov 1, 2022·0 cites·17 claims
- 3364US2022073625A1Humanized anti-axl antibodiesBERGENBIO ASA·Filed 2021·Application pending·0 cites
- 3463US11976122B2Anti-IL13Rα2 antibodiesADC THERAPEUTICS SA·Filed 2021·Granted May 7, 2024·0 cites·13 claims
- 3563US2023201366A1Anti-psma conjugatesADC THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 3663US2023285580A1Anti-il-13ralpha2 conjugatesADC THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 3762US2025163488A1Conjugation method involving a transglutaminase at the fc region comprising a trimmed n-glycanADC THERAPEUTICS SA·Filed 2023·Application pending·0 cites
- 3861US11384098B2Pyrrolobenzodiazepine-antibody conjugatesADC THERAPEUTICS SA·Filed 2018·Granted Jul 12, 2022·0 cites·25 claims
- 3961US2021137940A1Pyrrolobenzodiazepine-anti-psma antibody conjugatesMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 4061US2022096654A1Pyrrolobenzodiazepine-antibody conjugates and uses thereofADC THERAPEUTICS SA·Filed 2021·Application pending·0 cites
- 4160US2025186604A1Anti-psma antibody conjugatesADC THERAPEUTICS SA·Filed 2024·Application pending·0 cites
- 4260US2025121084A1Anti-claudin-6 conjugatesADC THERAPEUTICS SA·Filed 2024·Application pending·0 cites
- 4358US11059893B2Humanized anti-AXL antibodiesBERGENBIO ASA·Filed 2016·Granted Jul 13, 2021·0 cites·11 claims
- 4458US2020405873A1Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 4557US2025352658A1Combination therapy using antibody-drug conjugatesADC THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 4656US2016256561A1Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2014·Application pending·0 cites
- 4755US2020405879A1Combination therapyADC THERAPEUTICS SA·Filed 2018·Application pending·0 cites
- 4852US2025152725A1Combination therapy with an anti-axl antibody-pbd conjugate and nanocupsOXSONICS LTD·Filed 2023·Application pending·0 cites
- 4952US2015273077A1Pyrrolobenzodiazepine-anti-her2 antibody conjugatesADC THERAPEUTICS S RL·Filed 2013·Application pending·0 cites
- 5051US2019015524A1Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →